NO163184C - Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. - Google Patents
Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater.Info
- Publication number
- NO163184C NO163184C NO845176A NO845176A NO163184C NO 163184 C NO163184 C NO 163184C NO 845176 A NO845176 A NO 845176A NO 845176 A NO845176 A NO 845176A NO 163184 C NO163184 C NO 163184C
- Authority
- NO
- Norway
- Prior art keywords
- benzoksazin
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/16—Derivatives of isocyanic acid having isocyanate groups acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
- C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
- C07C273/1827—X being H
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56612983A | 1983-12-27 | 1983-12-27 | |
| US60860984A | 1984-05-09 | 1984-05-09 | |
| US06/673,996 US4657893A (en) | 1984-05-09 | 1984-11-26 | 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO845176L NO845176L (no) | 1985-06-28 |
| NO163184C true NO163184C (no) | 1990-04-18 |
Family
ID=27415984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO845176A NO163184C (no) | 1983-12-27 | 1984-12-21 | Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0147211B1 (fi) |
| KR (1) | KR890000992B1 (fi) |
| CA (1) | CA1269800A (fi) |
| DE (1) | DE3483204D1 (fi) |
| DK (1) | DK625184A (fi) |
| ES (2) | ES8607260A1 (fi) |
| FI (1) | FI79842C (fi) |
| HU (1) | HU195648B (fi) |
| IL (1) | IL73943A (fi) |
| NO (1) | NO163184C (fi) |
| NZ (1) | NZ210669A (fi) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1309556C (en) * | 1987-06-09 | 1992-10-27 | Masayuki Kokubo | 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases |
| ES2067140T3 (es) * | 1990-09-10 | 1995-03-16 | Asahi Chemical Ind | Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos. |
| US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
| US5985872A (en) * | 1995-05-24 | 1999-11-16 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
| GB9700597D0 (en) * | 1997-01-14 | 1997-03-05 | Sandoz Pharma Uk | Organic compounds |
| US6180625B1 (en) | 1998-03-24 | 2001-01-30 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| AU2826099A (en) * | 1998-03-24 | 1999-10-18 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| WO2000030646A1 (en) * | 1998-11-26 | 2000-06-02 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
| EP1147091A2 (en) | 1999-01-22 | 2001-10-24 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| NZ529822A (en) | 1999-01-22 | 2005-11-25 | Elan Pharm Inc | Acyl derivatives which treat VLA-4 related disorders |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| CN101273035A (zh) | 2005-09-29 | 2008-09-24 | 伊兰制药公司 | 抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物 |
| DK1940826T3 (da) | 2005-09-29 | 2011-04-18 | Elan Pharm Inc | Pyrimidinylamidforbindelser, der inhiberer leukocytadhæsion medieret gennem BLA-4 |
| MX2008010988A (es) | 2006-02-27 | 2008-10-20 | Elan Pharm Inc | Compuestos de pirimidinil sulfonamida que inhiben la adhesion de los leucocitos mediada por vla-4. |
| CA2760151A1 (en) | 2009-04-27 | 2010-11-04 | Elan Pharmaceuticals, Inc. | Pyridinone antagonists of alpha-4 integrins |
| US20200109126A1 (en) * | 2017-01-06 | 2020-04-09 | The Regents Of The University Of California | Mu opioid receptor modulators |
| AU2019247842B2 (en) | 2018-04-04 | 2023-08-31 | Epiodyne, Inc. | Opioid receptor modulators and products and methods related thereto |
| TW202304869A (zh) | 2021-04-05 | 2023-02-01 | 美商艾碧奧戴股份有限公司 | 類鴉片受體調節劑 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3450700A (en) * | 1966-12-20 | 1969-06-17 | Upjohn Co | 2-tertiary amino-4h-3,1-benzoxazin-4-ones |
| DE2315303A1 (de) * | 1973-03-27 | 1974-10-17 | Bayer Ag | Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen |
-
1984
- 1984-12-20 NZ NZ210669A patent/NZ210669A/en unknown
- 1984-12-21 NO NO845176A patent/NO163184C/no unknown
- 1984-12-21 DK DK625184A patent/DK625184A/da not_active Application Discontinuation
- 1984-12-21 CA CA000470962A patent/CA1269800A/en not_active Expired - Fee Related
- 1984-12-21 EP EP84309013A patent/EP0147211B1/en not_active Expired - Lifetime
- 1984-12-21 DE DE8484309013T patent/DE3483204D1/de not_active Expired - Fee Related
- 1984-12-26 KR KR1019840008352A patent/KR890000992B1/ko not_active IP Right Cessation
- 1984-12-26 ES ES539038A patent/ES8607260A1/es not_active Expired
- 1984-12-26 IL IL73943A patent/IL73943A/xx unknown
- 1984-12-27 HU HU844839A patent/HU195648B/hu not_active IP Right Cessation
- 1984-12-27 FI FI845116A patent/FI79842C/fi not_active IP Right Cessation
-
1986
- 1986-01-14 ES ES550879A patent/ES8703437A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL73943A0 (en) | 1985-03-31 |
| ES550879A0 (es) | 1987-03-01 |
| HUT36808A (en) | 1985-10-28 |
| DE3483204D1 (de) | 1990-10-18 |
| FI79842C (fi) | 1990-03-12 |
| EP0147211B1 (en) | 1990-09-12 |
| KR890000992B1 (ko) | 1989-04-15 |
| EP0147211A3 (en) | 1985-08-14 |
| FI845116L (fi) | 1985-06-28 |
| EP0147211A2 (en) | 1985-07-03 |
| DK625184A (da) | 1985-06-28 |
| DK625184D0 (da) | 1984-12-21 |
| ES539038A0 (es) | 1986-06-01 |
| IL73943A (en) | 1989-01-31 |
| CA1269800A (en) | 1990-05-29 |
| ES8607260A1 (es) | 1986-06-01 |
| HU195648B (en) | 1988-06-28 |
| FI79842B (fi) | 1989-11-30 |
| NZ210669A (en) | 1988-05-30 |
| ES8703437A1 (es) | 1987-03-01 |
| NO845176L (no) | 1985-06-28 |
| FI845116A0 (fi) | 1984-12-27 |
| KR850004472A (ko) | 1985-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163451C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater. | |
| NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
| NO165838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser. | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO162764C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater. | |
| NO162022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater. | |
| NO159531C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater. | |
| NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
| NO156864B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
| NO163184C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
| NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
| NO161676C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater. | |
| NO164169C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater. | |
| NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
| NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO161738C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater. |